Larvol Delta - MiRisten-for-the-Treatment-of-Relapsed-or-Refractory-Acute-Myeloid-Leukemia

miRisten - Thalia Therapeutics

http://clinicaltrials.gov/ct2/show/NCT07025564

Jul 25, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next